18-methoxycoronaridine

DB15096InvestigationalSmall molecule

18-methoxycoronaridine is under investigation in clinical trial NCT03084952 (Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients).

Chemical structure of 18-methoxycoronaridine
Formula / weight
C22H28N2O3 · 368.477 g/mol (avg)

Resolves to

Compound
UNIIKX8NQX91Z8CAS308123-60-6
Structure
InChIKeyDTJQBBHYRQYDEG-SVBQBFEESA-NSMILESCOCC[C@H]1C[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@](C2)([C@H]13)C(=O)OC
Targets
P32297CHRNA3Q15822CHRNA2

What you can answer from here — as of April 02, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with 18-methoxycoronaridine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In